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Previous studies in developing Xenopus and zebrafish reported that the phosphate
transporter slc20a1a is expressed in pronephric kidneys. The recent identification of
SLC20A1 as a monoallelic candidate gene for cloacal exstrophy further suggests its
involvement in the urinary tract and urorectal development. However, little is known
of the functional role of SLC20A1 in urinary tract development. Here, we investigated
this using morpholino oligonucleotide knockdown of the zebrafish ortholog slc20a1a.
This caused kidney cysts and malformations of the cloaca. Moreover, in morphants we
demonstrated dysfunctional voiding and hindgut opening defects mimicking imperforate
anus in human cloacal exstrophy. Furthermore, we performed immunohistochemistry
of an unaffected 6-week-old human embryo and detected SLC20A1 in the urinary
tract and the abdominal midline, structures implicated in the pathogenesis of cloacal
exstrophy. Additionally, we resequenced SLC20A1 in 690 individuals with bladder
exstrophy-epispadias complex (BEEC) including 84 individuals with cloacal exstrophy.
We identified two additional monoallelic de novo variants. One was identified in a case-
parent trio with classic bladder exstrophy, and one additional novel de novo variant
was detected in an affected mother who transmitted this variant to her affected son.
To study the potential cellular impact of SLC20A1 variants, we expressed them in
HEK293 cells. Here, phosphate transport was not compromised, suggesting that it is
not a disease mechanism. However, there was a tendency for lower levels of cleaved
caspase-3, perhaps implicating apoptosis pathways in the disease. Our results suggest
SLC20A1 is involved in urinary tract and urorectal development and implicate SLC20A1
as a disease-gene for BEEC.
Keywords: SLC20A1, urinary tract development, kidney formation, zebrafish development, cloacal malformation,
functional genetics, CAKUT, bladder exstrophy-epispadias complex
INTRODUCTION
The recent identification of the phosphate transporter
SLC20A1 as a candidate gene for cloacal exstrophy (CE)
(OMIM 258040) suggests its involvement also in the lower
urinary tract and urorectal development (Reutter et al.,
2016). While previous studies in developing Xenopus and
zebrafish (zf) reported the expression pattern of slc20a1a
in pronephric kidneys (Nichane et al., 2006; Raciti et al.,
2008; Howe et al., 2012; Zhang et al., 2017), the possible
role of SLC20A1 in urinary tract formation is unknown.
SLC20A1 encodes for the sodium-phosphate symporter
called the solute carrier family 20 member 1 (PiT-1). The
SLC20A1 protein comprises 12 transmembrane domains
(TMDs) (O’Hara et al., 1990; Farrell et al., 2009). Slc20a1
(PiT-1) knock-out mice die by embryonic day 12 (Beck
et al., 2009; Festing et al., 2009). While the exact cause
of death is unknown, they have gross defects in yolk sac
vascular development putatively correlating with Slc20a1
regulating endocytosis and microautophagy within yolk sac
visceral endoderm (Beck et al., 2009; Festing et al., 2009;
Wallingford and Giachelli, 2014).
Due to their ease of molecular manipulation and real-time
observation, and the high fecundity of the species, we successfully
used zebrafish larvae (zfl) to functionally characterize dominant
variants reported in individuals with lower urinary tract
obstruction (Kolvenbach et al., 2019). Here, we apply a similar
zf model to investigate the role of slc20a1a in the zf urinary
tract and urorectal development, and we combine this with
human genomic, cell culture, and immunohistochemistry with
regard to SLC20A1. Our results suggest SLC20A1 is involved
in human and zf urinary tract and urorectal development, and
implicate SLC20A1 as a disease-gene for bladder exstrophy-
epispadias complex (BEEC). Our study also provides early
cell culture data to suggest that SLC20A1 variants found in
patients affect cleaved caspase-3, consistent with a reported
role of SLC20A1 in tumor necrosis factor-induced apoptosis
(Salaün et al., 2010).
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MATERIALS AND METHODS
Zebrafish Husbandry and Embryo
Preparation
Zf were kept according to national law and to recommendations
by Westerfield (Westerfield, 2000) in our fish facility. Zfl
of wild-type AB/TL and transgenic strain Tg(wt1b:eGFP)
(Perner et al., 2007) were gained by natural fish spawning
and raised at 28 C in Danieau (30%) medium on a 14 h
light:10 h dark cycle. All zf experiments were performed
at ≤ 5 dpf before independent feeding. To suppress
pigmentation for later, WISH analysis or fluorescent
microscopy 1-phenyl-2-thiourea (final concentration 0.003%)
was added to the Danieau solution for respective zfl from
1 dpf onward. Staging of zfl was performed according to
Kimmel et al. (1995).
Microinjections of Morpholino
Oligonucleotides and mRNA
Zebrafish embryos were collected 15 min after breeding and were
pressure injected into the yolk at the one-cell stage (up to 30–40
min after fertilization) with an ATG-blocking Morpholino R©
antisense oligonucleotide (MO) by GeneTools, LLC. Injections
were carried out with 0.75 ng of slc20a1a MO (1.7 nL/embryo)
(5′CTGGAGAAAAACACTTCTGGCCTAC 3′) and 0.75 ng of
standard control MO (5′CCTCTTACCTCAGTTACAATTTATA
3′). For pressure injection, we used the “Milli-Pulse
Pressure Injector, Model MPPI-3” (Applied Scientific
Instrumentation, Inc. 29391 W. Enid Rd. Eugene, OR
97402-9533, United States). The MPPI-3 is a self-contained
device for producing gas pressure pulses to an injection
needle (pulled glass capillary–GB120F-10, Science Products
GmbH). The unit offers linear control of both pressure and
pulse duration.
Morpholino (MO) mRNA Rescue
Rescue experiments were performed by co-injection of MO
together with 35 pg of human SLC20A1 polyA mRNA.
In vitro transcription of SLC20A1 mRNA was performed
using mMessage mMachine Kit (Ambion 1340M) and
Poly-A-Tailing-Kit (Ambion AM1350) on IMAGE-clone:
3918690. slc20a1a MO sequence is not homologous to
the hSLC20A1 mRNA (0% homology), excluding binding
of the MO to hSLC20A1 mRNA (Supplementary Data
Sheet S16).
Western Blot (WB) Analysis in slc20a1a
MO Knockdown (KD) zfl
After grading, zfl were pooled into samples of 20–30
larvae of equal grades and lysed in RIPA buffer on ice
with 4% protease inhibitor using a sonicator. Proteins
were separated by SDS-PAGE, transferred on PVDF
membranes and were probed with anti-SLC20A1 (1:1000;
Sigma-Aldrich; AV43905) at 4◦C overnight. Enhanced
chemiluminescent (ECL) HRP substrate for low-femtogram-level
detection was used.
Sulforhodamine 101 (SR101) Excretion
Assay
Excretion assay was performed on days 4–5 dpf. Zfl were kept in
the dark in 0.02 mM SR101 in Danieau 30% + 0.003% 1-phenyl-
2-thiourea solution for 1 h. After incubation zfl were washed with
Danieau 30% three times for 10 min before imaging.
Whole-Mount Zebrafish in situ
Hybridization (WISH)
cDNA plasmids for the preparation of antisense and sense probes
for pax2a, evx1, slc20a1a, and slc20a1b were generated by PCR
from zebrafish poly-T embryonic cDNA (primer sequences are
provided in Supplementary Data Sheet S15). The resulting
amplified PCR products were cloned into SK(-) pBluescript R©.
Constructs were linearized by corresponding restriction enzymes
and DIG-labeled sense and anti-sense RNA was synthesized using
Roche DIG RNA Labeling Kit (Cat. No. 11 175 025 910). WISH




Zfl were fixed in 4% paraformaldehyde overnight at 4◦C and
washed afterward with methanol in increasing concentration
(25, 50, 75, 100%). Heat-induced antigen retrieval was
performed in Tris-HCL (pH = 8.5) at 70◦C for 15 min.
For permeabilization digest with Proteinase K at room
temperature was adapted to age of the zfl. They were then
incubated in primary antibodies for 3 days at 4◦C (1:500;
Anti-Acetulated Tubulin: Sigma-Aldrich – T7451, mouse; Anti-
GFP: Invitrogen – A11122, rabbit) and secondary antibodies
for 2 days at 4◦C (1:1000; Alexa Fluor 546 goat anti-mouse:
LifeTechnologies – A11030; Alexa Fluor 488 goat anti-rabbit:
LifeTechnologies – A11034).
High Resolution in vivo Fluorescent Zfl
Imaging
Embryos were pre analyzed under a Nikon AZ100 Macro-Zoom
microscope and selected embryos were further anesthetized
with 0.016% tricaine, mounted in 2% low-melting agarose and
imaged by two-photon scanning fluorescence in vivo microscopy
(LaVision Trim-Scope II; ImSpector and ImageJ software).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism version
8.0.0 for Mac, GraphPad Software, San Diego, CA, United States1.
Differences with a p-value of < 0.05 (∗) were considered as being
statistically significant. Error bars show standard deviation (SD)
in all experiments.
Human Embryo Immunohistochemistry
Human tissues, collected after maternal consent and ethical
approval (REC 08/H0906/21 + 5), were provided by the MRC
1www.graphpad.com
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FIGURE 1 | slc20a1a MO KD. KD was performed by injecting 0.75 ng of ATG-blocking MO into one-cell-staged wt zf eggs. Lateral view, dorsal to top, cranial on the
left. (A) Phenotypical grading of MO injected zfl at 2 dpf in four grades increasing in severity and lethality. Scale bar: 500 µm. See main Results text for grading
details. In brief, GI were normal in direct inspection; GII had mild defects; GIII had moderate defects, and GIV had severe defects. G V resembles dead zfl.
Supplementary Data Sheet S3 shows close-ups for better demonstration of hydrocephalus and eye development in all four grades presented. (B) Examples for
cloacal abnormalities in MO KD zfl at 2 dpf. Scale bar: 100 µm. Inspection of cloacal region after previous grading revealed malformations in cloacal region in G II
and G III sorted zfl increasing in amount and severity with grading. G I sorted zfl had normal cloacal morphology, that is, a thin and curved organ with a distal opening
(arrow). GII and GIII zfl have abnormally shaped cloacae, with dilated and/or apparently blind-ending lumens. Further cloacal close-ups of G II and III sorted zfl are
shown in Supplementary Data Sheet S4. (C) WB shows efficacy of MO KD in zebrafish protein lysates from 2 dpf. 70 kDa: slc20a1a, 42 kDa: ß-Actin loading
control; WT = uninjected control, Crtl = control MO injected, G II/III/IV = slc20a1a MO KD zfl sorted by grading II–IV. Slc20a1a can be detected in uninjected wt
control and injected control MO group. Only a weak slc20a1a signal was seen in MO KD groups G II, III, and IV, which showed phenotypical features as described in
(A). WB shows correlation between phenotype and protein expression. Raw data of WB is shown in Supplementary Data Sheet S6. (D) Co-injection of slc20a1a
MO with 35 µg in vitro transcribed human SLC20A1 polyA mRNA shows partial rescue of various phenotypes underlining the Morpholino’s specificity. n = 5 (here
n = 1 represents the average score in each experimental batch). Error bars show SD. X-axis shows groups at 3 dpf that were compared: zfl showing no or only a
very mild phenotype (G I + G II), larvae with a moderate phenotype (G III) and a last group of larvae with a severe and lethal phenotype (G IV) together with those who
were already dead at time of comparison (G V). Y-axis shows the percentage of zfl in the corresponding groups described before. A significant difference (∗p = 0.01)
was seen within the first group of MO and MO-mRNA rescue group, showing a partial rescue of slc20a1a MO KD phenotype reflected in bigger group of
phenotypically not or only mildly affected zfl. Mere overexpression of SLC20A1 wt mRNA in zfl resulted in phenotypical aberrations, which did not fit the grading
characteristics and the phenotypes observed in slc20a1a MO KD. Further, pure SLC20A1 overexpression in zfl resulted in higher lethality compared to non-injected
control groups (data not shown). These findings suggest that the MO rescue effect of SLC20A1 wt mRNA is weakened and disguised by the mRNA’s general
negative overexpression effect. (E) Kaplan-Meyer curve shows significantly reduced survival (p < 0.0001) in slc20a1a MO-injected group compared to uninjected
and control MO. Survival rates by day five post-fertilization: WT = 100%, control MO injected group = 93%, MO injected group = 35% (including all grades).
Exclusion of embryos dying/not developing by 8 h post-fertilization (hpf) due to failed fertilization or consequences of tissue damage caused by injections with
mechanical manipulation. Within these initial 8 hpf intervals, no difference was seen between control MO and slc20a1a MO injected groups.
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and Wellcome Trust Human Developmental Biology Resource2.
Paraffin sections were processed for immunostaining after
antigen retrieval, essentially as described (Kolvenbach et al.,
2019). Sections were probed with antibody to SLC20A1 (1:200;
Proteintech 12423-1-AP).
Resequencing of SLC20A1 in Individuals
With BEEC
The resequencing study was conducted in adherence to the
Declaration of Helsinki. Informed consents were obtained from
affected individuals or by proxies in the case of minors. The
study was approved by the ethics committee of the medical
faculty of the University of Bonn (No. 031/19) as well as the
respective ethic committee of the collaborating centers in
Manchester (United Kingdom), Nijmegen (AGORA data- and
biobank; Netherlands; Rooij et al., 2016), Torino (Italy), and
Stockholm (for Sweden on behalf of Lund, Göteborg, and
Uppsala). For resequencing, 690 (440 male and 250 female)
BEEC individuals were included [epispadias n = 42; classic
bladder exstrophy (CBE) n = 564; CE n = 84]. All three human
SLC20A1 protein coding transcripts (ENST00000272542.7,
ENST00000423633.5, ENST00000433924.5) listed in “ensembl
database” (September 30, 2017)3 were sequenced. PCR-
amplified DNA products (primer sequences are provided in
Supplementary Data Sheet S15) were subjected to sequencing
using a 3130XL Genetic Analyzer (Applied Biosystems, Foster
City, United States).
Generation of Variants for in vitro
Analysis
QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent
#210518) was used to generate variants from IMAGE clone
3918690 (primer sequences are provided in Supplementary Data
Sheet S15).
Cloning for Cell Culture Experiments
N-terminally Flag tagged wild type (wt) and mutant SLC20A1
cDNA of human origin were cloned into pcDNA3 plasmid
backbone (Clontech) (primer sequences are provided in
Supplementary Data Sheet S15).
Cell Culture and Transient Transfection
HEK293 cells were cultured in DMEM/F12 (1:1) (GIBCO)+ 10%
fetal calf serum (FCS; GIBCO) + 1% penicillin (5,000
U/ml)/streptomycin (5,000 µg/ml). Cells were seeded 1:1 into 24
and six well plates, followed by transient transfection with 250–
1,000 ng plasmid DNA per cm2 well surface using PANfect A
transfection reagent (PAN Biotech, Germany). The experiments
were performed 48 h after transfection.
Western Blot Analysis in HEK293 Cells
Transient transfected HEK293 cells were harvested and lysed
in 75 µl homogenization buffer (250 mM sucrose; 20 mM
2http://www.hdbr.org/
3www.ensembl.org/
HEPES; 1 mM EDTA in distilled H2O, pH 7.4) with 1 mM
dithiothreitol; 100 µg of whole cell lysates were separated on 10%
sodium dodecyl sulfate (SDS) gels, transferred on nitrocellulose
membranes, and probed with antibodies against FLAG-tag
(1:1,000; Sigma Aldrich; F3165) and ß-ACTIN (1:40,000; Sigma
Aldrich; A3854). Non-transfected HEK293 cells served as
negative control. For analysis of cleaved caspase-3 (CC3) levels
20 µg of cell lysates were loaded and probed with anti-CC3
(1:2,000; Cell Signaling; 9661) and ß-ACTIN (1:10,000; Sigma
Aldrich; A5441). Analysis of proliferation cell nuclear antigen
(PCNA) levels was performed by blotting 2 µg of cell lysates
of all respective groups and probing those with anti-PCNA
(1:5,000; Abcam; ab2426) and ß-ACTIN. ImageJ was used for
WB densitometry.
Phosphate Uptake Assay in Human
Embryonic Kidney 293 (HEK293) Cells
Transient transfected HEK293 cells seeded on 24 well plates
were incubated in uptake buffer (96 mM NaCl; 2 mM KCl;
1.8 mM CaCl2; 1 mM MgCl2; 50 mM HEPES in distilled
H2O) supplemented with 200 µM potassium phosphate buffer
and 1 µCi 32PO43− per ml uptake buffer for 3and 15 min
before washing, respectively. Cell-associated radioactivity was
measured with a ß-counter (Tri-Carb R© Liquid Scintillation
Analyzer, Perkin Elmer). Values are given as counts per minute
and calculated as percentage. Non-transfected HEK293 cells
served as background control.
Computational 3D Structural Modeling
For 3D structure, modeling of human SLC20A1 variants
(Uniprot ID: Q8WUM9) I-Tasser4 was used. This employs
an integrated combinatorial approach comprising comparative
modeling, threading, and ab initio modeling (Roy et al., 2010)
using the procedure adopted by Dakal et al. (2017). The generated
structures were visualized in Chimera 1.13rc version.
RESULTS
Morpholino KD of slc20a1a in Embryonic
Zebrafish
To further functionally characterize SLC20A1 we performed
ATG-blocking MO KD experiments in zfl. The zf has two
ortholog genes, slc20a1a and slc20a1b. Focusing on the segment
of chromosome 2 harboring the SLC20A1 locus in humans, none
of the distinct chromosome loci of the two zf orthologs show
conserved syntenies to the human segment. NCBI Unigene’s
EST profile viewer reveals distinct expression patterns for both
zf orthologs (Nichane et al., 2006): only slc20a1a appears
to be strongly and specifically expressed in the embryonic
kidney. While in the developing zfl no specific expression has
been described for slc20a1b so far (January 2020)5, clearly
slc20a1a has been established as a pronephric tubular marker
4http://zhanglab.ccmb.med.umich.edu/I-TASSER/
5http://zfin.org/
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FIGURE 2 | Pronephric cysts in slc20a1a MO KD resulting from cloacal obstruction due to malformations. (A) Scheme of human abdomen, green: urogenital tract
with kidneys, ureter, bladder, urethra; blue: abdominal wall. (B) Pronephros in zfl (green: right side) as equivalent to human urinary tract. Scheme of zfl, dorsal view at
(Continued)
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FIGURE 2 | Continued
2 dpf, patterning of zebrafish pronephros is similar to human nephron segmentation. Specific segments are color coded (left side) for better identification: G,
Glomerulus; N, Neck; PCT, Proximal Convoluted Tubule; PST, Proximal Straight Tubule; DE, Distal Early; DL, Distal Late; CD, Collecting Duct. (C) Whole mount
in situ hybridization (WISH) against slc20a1a in zfl at 2 dpf, labeling proximal part of pronephros. Scale bar: 500 µm. (D) Control MO zfl in Tg(wt1b:GFP) (Perner
et al., 2007) marking proximal part of pronephros, Scale bar: 100 µm. (E) Glomerular close-ups in Tg(wt1b:GFP) zfl in dorsal view at 2 dpf (Scale bar: 50 µm). On
the left, pronephric cysts (arrows) and dilatation of proximal part of pronephros increasing in severity with grading are shown. G I (upper pictures) showing no cystic
phenotype, G II (middle pictures) showing a mild cyst formation, and G III (bottom pictures) showing severe cysts and a wide dilatation of the pronephros.
Corresponding cloacal close-ups, shown on the right in lateral view (Scale bar: 50 µm), underline correlation between malformations in urinary outflow tract and
cysts as well as pronephric dilatations in corresponding groups. (F) Graph shows percentage of zfl (Y-axis) in the following groups: Control MO, slc20a1a MO G I,
slc20a1a MO G II, slc20a1a MO G III (X-axis). Each dot stands for one individual experiment (here N = 1 represents the average score in each experimental batch).
Whereas control MO and slc20a1a MO G I larvae do not show any cystic phenotype, only an average of 21% of MO G II, and solely 3% of G III MO zfl show normal
configuration of the proximal part of pronephros. The graph shows significant differences between control MO and phenotypically normal group MO G I compared to
MO G II and G III, N = 3, ****p < 0.0001. Error bars show SD.
(Howe et al., 2012; Zhang et al., 2017). Here, WISH analysis
confirmed slc20a1a as a pronephric marker, with expression
in the proximal (i.e., near to the glomerulus) section, while
WISH analysis of slc20a1b did not show any signal in tissues
relevant to urinary tract development (Supplementary Data
Sheets S1A–F). Hence, we studied MO KD against slc20a1a to
characterize its possible developmental impact on urinary tract
and urorectal development. The injection procedure was uniform
in all experiments. slc20a1a MO injected larvae showed a range
of phenotypes on direct inspection. To facilitate analyses, we
graded all MO injected zfl at 2 dpf (Long-pec, according to
Kimmel et al., 1995) on the basis of several phenotypical features.
Representative images of the grades (G) are depicted in Figure 1.
In brief: G I embryos (5% at 2 dpf) appeared normal and identical
to uninjected and control MO injected zfl; G II zfl (6% at 2 dpf)
showed a mild phenotype with minimal reduction in body and
head sizes, no or moderate hydrocephalus, mild pigmentations
defects, and benign reduction of the yolk sac extension, but
without changes in body curvature or eye abnormalities; G III
zfl (46% at 2 dpf) showed a moderate phenotype characterized
by decreases in body and head sizes, overt hydrocephalus
(arrow heads, additional images in Supplementary Data Sheet
S3), yolk endocytosis defects, lack of yolk sac extension along
abdominal wall (arrows), eye abnormalities especially in size
(Supplementary Data Sheet S3), straight body with or without
kinking of the tail tip (no kinking shown here), pigmentation
defects, and pericardial effusion; and G IV zfl (27% at 2 dpf) had
marked malformations of various organ systems and additional
defects in body curvature. Remarkably, no G IV larvae survived
until 5 dpf and were therefore not further analyzed but scored
as “dead” (G V) in the statistics presented. Supplementary
Data Sheet S3 shows close-ups for better demonstration of
hydrocephalus and eye development in all four grades presented.
Cloacal Anomalies in slc20a1a MO KD
Though cloacal anomalies were not part of the preceding
grading, we frequently found malformations in the cloacal region
and therefore the urinary outflow tract in mild (GII) and
moderate (GIII) slc20a1a MO KD zfl (Figure 1B). These cloacal
malformations could themselves be graded as moderate or severe
(additional images in Supplementary Data Sheet S4). G I sorted
zfl had normal cloacal morphology, that is, a thin and curved
organ with a distal opening (arrow). G II and G III zfl has
abnormally shaped cloacae, with dilated and/or apparently blind-
ending lumens. Further cloacal close-ups of G II and III sorted
zfl are shown in Supplementary Data Sheet S4. Importantly,
the finding of cloacal anomalies in larvae that had only a mild
whole-body phenotype suggests that the former is a “strong”
primary effect and not simply a side effect of a more major whole-
body malformation. For further characterization, we performed
WISH in slc20a1a MO, control MO, and uninjected wt zfl with
two different cloacal marker probes at two timepoints each.
pax2a marks the distal part of the pronephric ducts up to their
fusion at the cloaca. For quantification of pax2a expression, we
determined the maximal distance orthogonal to the pronephric
midline within the stained cloacal region (Supplementary Data
Sheets S5A–C). evx1 is a WISH marker for the cloaca. The area
of staining was measured using a common threshold in all zfl
(Supplementary Data Sheets S5D–F). For pax2a, a wider cloaca
was found in slc20a1a MO KD zfl at both timepoints. Cloacal area
of expression of evx1 was significantly larger in slc20a1a MO KD
zfl at both timepoints as well. These results suggest a defect in
tissue development in the cloacal region of slc20a1a MO KD zfl.
Efficiency and Specificity of MO KD
Shown by WB Analysis and mRNA
Rescue
Efficacy of slc20a1a MO KD, at the protein level, was
demonstrated by WB analysis at 2 dpf (Figure 1C). Slc20a1a
protein was detected in both control groups at about 70 kDa
molecular weight. We could only detect weak slc20a1a protein
signal in the MO KD grades (G II–IV).
To test the specificity of our slc20a1a MO, we co-injected
in vitro transcribed polyA mRNA of human wt SLC20A1. We
detected a rescue effect of the human SLC20A1 mRNA in MO
zfl, as evidenced by significant increase of the proportion of
overtly normal or mildly affected zfl (GI+GII) (Figure 1D). This
effect was even more notable given the fact that overexpression
of SLC20A1 wt mRNA in non-morphant zfl resulted in
higher lethality and phenotypical aberrations, which did not
fit the grading characteristics and the phenotypes observed in
slc20a1a MO KD. Collectively, the results support the slc20a1a
MO’s specificity.
Survival of uninjected wt, control MO, and slc20a1a MO KD
zfl were monitored until 5 dpf, showing a significant decrease
(>50%) in survival rate in the MO KD larvae (Figure 1E).
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FIGURE 3 | Sulforhodamine 101 excretion assay shows imperforate hindgut in slc20a1a MO KD zfl. (A) Scheme of human abdomen, red = GIT with stomach,
duodenum, jejunum, ileum in light red and colon, rectum, anus in dark red; blue = abdominal wall. (B) Scheme of zfl, lateral view at 5 dpf; green = urogenital tract
(Continued)
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FIGURE 3 | Continued
(pronephros), red = GIT, blue = abdominal wall, beige = yolk sac, yellow = cloaca. (C) Cloaca in zfl at 5 dpf: fusion and opening of pronephros and GIT at cloaca
between 4 and 5 dpf. Pseudocolored for identification as above in B: green = urogenital tract (pronephros), red = GIT, yellow = cloaca. Scale bar: 50 µm.
(D) Opening of cloaca and excretion of SR101, a red fluorescent dye labeling the content of zfl intestine. Upper panel shows brightfield, middle panel red channel,
lower panel shows a merged view of both channels. On the left we show slc20a1a MO KD G I zfl at 5 dpf compared to slc20a1a MO KD G II zfl at 5 dpf on the right
side of the panel. In control MO and slc20a1a MO GI, zfl dye uptake is not disturbed; we could detect clear and bright red dye fluorescence in the gut of all animals.
Dye excretion and opening of the cloaca was not disturbed. White arrow marks dye excretion from the cloaca. In contrary, we observed cloacal opening and
excretion defects in slc20a1a MO KD G II zfl at 5 dpf mimicking an imperforate anus as shown on the right side of the panel. Black arrow marks opening defect and
therefore resulting dilatation of intestine due to bag log. No changes in peristalsis of the GIT was observed; hence, expansion of distal part of intestine as shown here
is solely caused by lack of cloacal opening. Scale bar: 50 µm. (E) Significant differences in opening of cloaca at 5 dpf in zfl between phenotypically affected and
control MO. Cloacal opening was monitored for several minutes up to 1 h. Only 13.25% of G II and 5.5% of G III zfl showed cloacal opening and therefore excretion
of SR101 from the GIT, whereas 82.5% of G II and 74% of G III zfl did not show any excretion. In the remaining 4.25% of G II and 20.5% of G III, zfl cloacal opening
could not be assessed resulting from failure of SR101 uptake in the first place or misshape and tissue malformations not allowing to assess the cloacal region in the
respective zfl. N = 4, ****p < 0.0001. Error bars show SD.
Pronephric Cysts and Dilatation of
Pronephric Ducts in slc20a1a MO KD
Implicate slc20a1a as Important Player in
Early Kidney Development
In zfl, the pronephros represents the anatomical structure that
corresponds to the human urinary tract. The pronephric pattern
is analogous to the mammalian nephron. The two pronephric
ducts fuse and excrete the urine through the cloacal opening
(Figures 2A,B). Figure 2C shows clear WISH signal for slc20a1a
in the proximal zfl pronephros at 2 dpf. slc20a1a WISH in
earlier developmental zfl stages show expression in intermediate
mesoderm, which later forms the pronephros, red blood cells,
and trunk endothelium (Supplementary Data Sheet S1). We
used Tg(wt1b:eGFP) reporter fish (Perner et al., 2007) to assess
the impact of slc20a1a on the development of the glomeruli
and the proximal region of the pronephros (Figure 2D).
Whereas control MO and slc20a1a MO G I zfl did not show
any phenotypical differences concerning the morphology of
the glomeruli and pronephros at 2 dpf, the majority of G
II (79%) and G III (97%) sorted larvae showed glomerular
cysts and a dilatation of the proximal part of the pronephric
ducts (Figures 2E,F).
We sought cilia within the pronephros using
immunofluorescence staining against alpha-acetylated tubulin
and GFP in Tg(wt1b:GFP) at 2 dpf. Our two-photon microscopy
(Supplementary Data Sheet S7) revealed the presence of
cilia. There were no gross structural anomalies, such as gross
shortening or elongation, between the G II and G III MO-KD zfl.
We did not, however, formally quantify cilia length nor did not
assess motility study in G II and G III MO-KD zfl. The dilatation
of their pronephric ducts was confirmed.
Dilatation of the ureter and pelvis of the kidney in human can
be caused by a backlog of urine due to a functional or anatomical
blockage of the urinary tract. This blockage occurs usually distal
to the dilated parts of the renal tract. slc20a1a MO KD zfl
show malformations in the urinary outflow tract (Figures 1B,
2E and Supplementary Data Sheet S4). Here, malformations of
urinary outflow tract in morphants correlate with severe cystic
dilatation of the pronephric kidney. This strongly supports the
hypothesis that the cloacal malformations seen in slc20a1a MO
KD zfl cause a backlog of urine, which leads to cystic and dilated
pronephric kidneys.
Sulforhodamine 101 Excretion Assay in
slc20a1a MO KD zfl Shows Gut Outlet
Obstruction at the Cloaca
Figure 3 depicts the gastrointestinal tract (GIT) and cloacal
opening of the hindgut. Schematic comparison of GIT of humans
and zf is shown in Figures 3A,B (red). The close-up of the cloacal
region in zfl shows opening of pronephros and GIT at cloaca in a
healthy zfl at 5 dpf (Figure 3C).
Fluorescent dye (Sulforhodamine 101, SR101) uptake and
excretion assay in zfl at 5 dpf showed normal excretion and
opening of the cloaca in all control MO zfl and in an average
of 98% in slc20a1a MO G I zfl (Figures 3D,E). On the
contrary, excretion of SR101 was severely disturbed and absent
in G II (82%) and G III (74%) slc20a1a MO zfl. This assay
confirmed the high abundance of cloacal opening defects in
slc20a1a morphants resembling an imperforate anus in humans.
For clarification of the performed dye assay, representative
fluorescent videos are provided in the supporting information
(Supplementary Data Sheets S8, S9).
Embryonic Protein Expression of
SLC20A1 in Human Embryonic
Urogenital Tissue
Figure 4A shows a transverse section of a healthy (non-BEEC) 6-
week gestation human embryo. SLC20A1 was immunodetected
in several locations including the urogenital sinus and the
urinary bladder precursor implicated in BEEC. Additionally, we
immunodetected SLC20A1 in a 10-week-gestation metanephric
kidney, with prominent signals in the proximal tubules and
collecting ducts (Figure 4B).
Resequencing of SLC20A1 Identifies Two
Additional Variants
Resequencing of all three genomic SLC20A1 transcripts identified
an additional de novo variant in a case-parent trio (c.893T > C,
p.Val298Ala, ENST00000272542.7, allele frequency 0.000003979,
Figure 4C, family 2, person I.1) as well as a novel de novo
variant in an affected mother (Figure 4C, family 3, person II.2)
who transmitted this variant to her affected son (c.1321A > C,
p.Lys441Gln, ENST00000272542.7, Figure 4C, family 3, person
I.1) (Supplementary Data Sheet S10 Table for additional
Frontiers in Cell and Developmental Biology | www.frontiersin.org 9 August 2020 | Volume 8 | Article 567
fcell-08-00567 August 6, 2020 Time: 20:32 # 10
Rieke et al. SLC20A1: Urinary Tract and Urorectal Development
FIGURE 4 | Exome sequencing and targeted Resequencing in families with BEEC phenotype identified disease variants in SLC20A1. (A) IHC of a transverse section
of a 6-week-old human embryo. SLC20A1 was immunodetected (brown) in the urogenital sinus (UGS), which develops into the urinary bladder. Furthermore,
(Continued)
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SLC20A1 was also detected in the spinal cord (SC), dorsal root ganglia (DRG), peripheric nerve trunk (PNT), hind limb (HL), hindgut (HG), migrating neural crest cells
(MNCC), umbilical cord (UC), Wharton’s jelly (WG), midgut (MG), and umbilical artery (UA). Scale bars = 100 µm. (B) Histology section of the human
10-week-gestation metanephric metanephros. Note prominent SLC20A1 immunostaining (brown) in the proximal tubule (PT) and the collecting duct (CD). The
glomerulus (G) shows a fainter signal. Scale bars: 100 µm. (C) Exome sequencing of eight CE case-parent-trios revealed de novo variant c.709G > A (p.Gly237Arg)
in SLC20A1 in family 1 (Reutter et al., 2016). Resequencing of 690 individuals with BEEC led to identification of two more variants in individuals with CBE:
c.893T > C (p.Val298Ala) in family 2 as de novo change c.1321A > C (p.Lys441Gln) with maternal inheritance (maternal phenotype: fusion defect of pelvic bone,
mild phenotype) in family 3. Pedigrees of all three families are shown with genotypes of all individuals indicated. In family 3, the maternal grandfather (Figure 1B,
family 3, person III.1) was not available for testing. For haplotype analysis of all available family members (Figure 1B, family 3, III.2, II.1, II.2, I.1), we used the
synonymous marker rs4849091 at chromosomal position chr2:113404708 A > G (p.Leu101=) of the canonical transcript ENST00000272542.7. Genotypes of
rs4849091 are shown in brackets. All variants are heterozygote changes and result in missense variants as shown in Sanger sequences including amino acid
sequences below each pedigree.
information). In this family, the maternal grandfather of the
index person (Figure 4C, family 3, person III.1) was not available
for testing. Haplotype analysis of all available family members
(Figure 1B, family 3, III.2, II.1, II.2, I.1) showed that the disease
variant (c.1321A > C) must have occurred de novo in the
grandmother’s derived germ cell (Figure 4C, family 3, person
III.2). For haplotype analysis, we used the synonymous marker
rs4849091 at chromosomal position chr2:113404708 A > G
(p.Leu101) of the canonical transcript ENST00000272542.7.
According to gnomAD this marker has a MAF of 0.4871 across
all ethnicities and resides in exon 8 of SLC20A1 in proximity of
12 kb to variant c.1321A > C.
Prediction of Variant Localizations in
SLC20A1
The SLC20A1 (PiT-1) protein is a sodium-dependent inorganic
phosphate (Pi) symporter that contains 12 TMDs (O’Hara et al.,
1990; Farrell et al., 2009). Three-dimensional crystal structures of
most SLC family transmembrane proteins are unknown (Dakal
et al., 2017). Figure 5A shows TMDs 6 to 9 of a putative 2D
structure of the SLC20A1 protein, modeled by Beck et al. (2009).
Here, variant c.709G > A (p.Gly237Arg) of family 1 is located
in TMD 7, and both variants, c.893T > C (p.Val298Ala), of
family 2 and variant c.1321A > C (p.Lys441Gln) of family 3
are located in a large intracellular loop between TMDs 7 and 8.
A further attempt of ours to predict localization of the variants
in a 3D model of SLC20A1 protein is shown in Supplementary
Data Sheet S11. Our 3D model confirmed the localization of
the two variants c.893T > C (p.Val298Ala) and c.1321A > C
(p.Lys441Gln) in a large intracellular loop between TMD 7 and
8. The focus is on c.709G > A (p.Gly237Arg), though we predict
a possible shift from TMD 7 (as described by Beck et al., 2009)
to TMD 6 in our 3D model. In transmembrane proteins, glycine
resides in helices, predominantly at the helix-helix interface,
which makes it an important structural player (Li and Deber,
1992; Javadpour et al., 1999). In our proposed 3D model,
p.Gly237Arg is present at the interface of TMD 6 and TMD 1.
Accordingly, p.Gly237Arg might cause instability in TMD 6.
Functional Characterization of SLC20A1
Variants in vitro
In vitro characterization of all three SLC20A1 variants was
performed using HEK293 cells transfected with either human
wt SLC20A1 or one of the three respective variants – all
FLAG-tagged. Transfection efficiency was confirmed by WB
(Figure 5B). Variant c.709G > A (p.Gly237Arg) was not
expressed efficiently in HEK293 cells as protein. A dosage effect
was excluded (Supplementary Data Sheet S12). Expression of
c.893T > C (p.Val298Ala) and c.1321A > C (p.Lys441Gln)
variants resulted in protein levels similar to that of expressed
wt SLC20A1 protein. Phosphate uptake in the transfected
cells was measured in a radioactive labeled phosphate assay
(Figure 5C). Untransfected HEK293 cells and c.709G > A
(p.Gly237Arg) transfected cells displayed a basal phosphate
uptake. Cells transfected with either human SLC20A1 wt,
c.893T > C (p.Val298Ala) or c.1321A > C (p.Lys441Gln) had
a threefold increased capability of phosphate uptake compared
to untransfected control cells. We therefore conclude that
SLC20A1-linked phosphate uptake is not disturbed by the two
de novo variants.
Given that SLC20A1 protein is known to play a role in
apoptosis pathways (Salaün et al., 2010; Husseini et al., 2013)
we used WB to assess the apoptosis marker CC3 in the
above described transfected HEK293 cells. Overexpression of wt
SLC20A1 increased the level of CC3. In order to quantify CC3
detection in WB, we performed densitometry (Figure 5D and
Supplementary Data Sheet S13). In contrast to wt SLC20A1,
variant c.893T > C (p.Val298Ala) failed to increase CC3 levels
above those in control cells. Variant c.1321A > C (p.Lys441Gln)
increased CC3 levels but to a lesser extent compared to wt
SLC20A1 overexpression. Variant c.709G > A (p.Gly237Arg)
was not studied further due to its expression deficiency in
HEK cells previously mentioned (Figure 5B and Supplementary
Data Sheet S12). We conclude that overexpression of BEEC
variants shows differences compared to wt overexpression
when analyzing expression of CC3 as an apoptosis marker.
Additionally, we performed WB analysis of the proliferation
marker PCNA (Figure 5E and Supplementary Data Sheet S13)
and found no significant differences in PCNA levels between
the experimental groups; yet, our data shows a trend: while wt
SLC20A1 overexpression was associated with a reduced PCNA
level, neither c.893T > C (p.Val298Ala) nor c.1321A > C
(p.Lys441Gln) had a similar strong effect.
DISCUSSION
The results of our study suggest that SLC20A1 is not only
involved in embryonic kidney formation but also in urinary
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FIGURE 5 | SLC20A1 as transmembrane phosphate transporter and in vitro characterization of its variants found in BEEC individuals. (A) In silico 2D model of
SLC20A1, a multi-pass integral membrane protein, indicating localization of variants found in affected individuals, c.709G > A (p.Gly237Arg) in TMD 7, c.893T > C
(p.Val298Ala) and c.1321A > C (p.Lys441Gln) are located in an intracellular loop. Only four (6–9) of a total of twelve TMDs are shown in this simplified model. The
model was generated based on the data of Beck et al. (2009). (B,C) SLC20A1 mediated 32PO4 transport in transiently transfected HEK293 cells. (B) WB analysis of
100 µg whole cell homogenates obtained from HEK293 cells transfected with 500 ng plasmid DNA per cm2 well surface. Plasmid DNA was FLAG tagged and
transfection efficiency was detected using anti-FLAG antibody (70 kDa) and anti-ß-ACTIN antibody (42 kDa), which served as loading control. As expected, no FLAG
signal could be detected in negative control (untransfected HEK293 cells, marked as HEK). Transfection worked for wt SLC20A1 overexpression as well as the
variants c.893T > C (p.Val298Ala) and c.1321A > C (p.Lys441Gln). No FLAG signal could be detected for c.709G > A (p.Gly237Arg) transfected cells. Even when
transfected with higher plasmid concentrations, p.Gly237Arg was not detectable in HEK293 cells (Supplementary Data Sheet S12). (C) Endpoint assay of
transient transfected HEK293 cells. Cells were incubated with 1 µCi 32PO43- and 200 µM K3PO4 for 15 min. For better comparison, a highest number of counts per
minute in wt SLC20A1 overexpression group was set as 100% in each experiment (N = 6 with two datasets each), values of HEK293 and variants were calculated
correspondingly, and resulting values in percentage are shown on the y-axis (Error bars show SD). A two-way ANOVA of the grouped analysis was significant
(Continued)
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(p < 0.0001). p.Gly237Arg did not show any differences of phosphate uptake to negative HEK293 control. This is in line with the expression deficiency of
p.Gly237Arg described before. Wt SLC20A1 overexpression showed a significant increase of phosphate uptake compared to untransfected HEK293 (Tukey’s
multiple comparison: ****p < 0.0001). Amin acid change p.Lys441Gln and p.Val298Ala overexpression resulted in an even higher phosphate uptake than wt
SLC20A1 overexpression with a significant difference between p.Val298Ala and wt SLC20A1 (Tukey’s multiple comparison: *p < 0.05). Therefore, variant
overexpression does not impair phosphate uptake capability in vitro. (D,E) Densitometric analysis of WBs (N = 6) from whole cell homogenates was obtained from
transfected HEK293 cells. WBs are provided in Supplementary Data Sheet S13. Y-axis shows normalized values against wt SLC20A1 overexpression. Error bars
show SD. (D) Expression of CC3 as apoptosis marker was measured in six WBs of corresponding independent transfection experiments. The one-way ANOVA was
significant (p = 0.0002), Tukey’s multiple comparison test was significant for HEK293 vs. WT (***p = 0.0005), and WT vs. p.Val298Ala (**p = 0.0038). Wt SLC20A1
overexpression in HEK293 cells increased apoptosis when compared to untransfected negative control (HEK). There is no induction of apoptosis inc.893T > C
(p.Val298Ala) transfected cells, comparable to untransfected negative control (HEK). c.1321A > C (p.Lys441Gln) does not result in significant reduction of CC3
expression. However, a trend of reduced CC3 expression in comparison to wt SLC20A1 overexpression can be seen. (E) Same analysis was used to study
expression of PCNA as a proliferation marker. A one-way ANOVA did not show significant results (p = 0.1903). Nevertheless, wt SLC20A1 overexpression seems to
reduce PCNA expression when compared to negative control (untransfected HEK). Variants analyzed [c.893T > C (p.Val298Ala) and c.1321A > C (p.Lys441Gln)]
tend to reduce PCNA less than WT overexpression (red dotted line for better comparison).
tract and urorectal development. Furthermore, our findings
suggest that monoallelic de novo variants in SLC20A1 are
involved in BEEC formation. These conclusions are supported
by the immunodetection of SLC20A1 in the BEEC relevant
developmental organ field comprising the urogenital sinus
and early human embryonic kidney. In this context, CBE
and CE individuals present with an increased incidence
of kidney and upper urinary tract anomalies comprising
ureteropelvic junction obstruction, ectopic pelvic kidney,
horseshoe kidney, kidney hypo- or agenesis, megaureter, ureteral
ectopy, and ureterocele (Stec et al., 2012). Accordingly, we
observed dilatation of the proximal part of pronephric ducts
in slc20a1a MO KD zfl. From our morphological description
of slc20a1a MO KD, it appears that the observed cystic
dilatations and the dilatation of the pronephros are due to
urinary backlog caused by pronephric outlet obstruction
(Figures 1B, 2E and Supplementary Data Sheet S4). The
latter interpretation resembles human hydronephrosis due to
vesicoureteral reflux rather than a primary architectural defect of
the pronephric mesenchyme.
In accordance with previous work, our WISH analysis
confirms slc20a1a in zfl as specific pronephric marker in 48
hpf zfl (Figure 2C). Interestingly, expression of slc20a1a in zfl
in earlier stages is not restricted to the proximal pronephric
area but can be seen in the intermediate mesoderm as well
as in the cloacal region (Supplementary Data Sheet S1).
Whether slc20a1a is expressed in the cloacal tissue cannot be
confirmed be our current data. Our data suggests slc20a1a
as regulator of early urinary tract and kidney formation.
The wide range of phenotypes that affect several organ
systems seen in slc20a1a MO KD zfl stresses the importance
of slc20a1a in early zf development. It not only alters the
cloacal formation but leads to developmental defects of
the eye, spine, and brain. Interestingly, the description of
the phenotypical features of slc20a1a MO KD zfl matches
phenotypes seen by Nathaniel Abraham (Abraham, 2004). In
their study, Abraham used the autophagy specific inhibitor
3 methyladenine (3MA) and caspase 3 inhibitor Z-DEVD-
FMK in developing zf embryos to study inhibition of
two apoptosis pathways. The striking similarities between
those zfl treated by Abraham with 3MA and Z-DEVD-
FMK and our slc20a1a MO KD zfl suggest a defect in
apoptosis due to KD of slc20a1a. This is in line with
our overexpression studies of identified BEEC variants in
HEK293 cells. Overexpression of both newly identified de
novo variants in HEK293 cells resulted in lower CC3 levels
compared to overexpression of wt hSLC20A1 (Figure 5D and
Supplementary Data Sheet S13) suggesting that both variants
interfere with apoptosis.
Previous exome sequencing in case-parent-trios with CE
identified a novel de novo variant in SLC20A1 (Reutter et al.,
2016). Here, we identified two additional de novo variants in
SLC20A1 in two independent BEEC families. Of the three de
novo variants identified so far, the variant with the highest
predicted functional impact (c.709G > A, p.Gly237Arg, family
1) locates in TMD 7 of SLC20A1 (Figures 5A–D model). In
the case of transmembrane proteins, glycine resides in helices
predominantly at the helix-helix interface and thus plays a major
structural role (Li and Deber, 1992; Javadpour et al., 1999). The
amino acid change p.Gly237Arg is located in a transmembrane
helix, but whether it is lying at a helix-helix interface cannot be
determined using the 2D model by Beck et al. (2009). However,
in our 3D model, p.Gly237Arg lies in TMD 6 and is present at
the interface of TMD 6 and TMD 1 (Supplementary Data Sheet
S11), suggesting that this variant might lead to instability in TMD
6. Expression deficiency of c.709G > A (p.Gly237Arg) in HEK293
cells points to the high impact of this variant on gene and
protein function. According to the 2D and 3D model of SLC20A1
protein, variant c.893T > C (p.Val298Ala, family 2) and variant
c.1321A > C (p.Lys441Gln, family 3) locate both in the large
intracellular loop of SLC20A1 between TMD 7 and 8 (Figure 5A
and Supplementary Data Sheet S11). Compared to variant of
c.709G > A (p.Gly237Arg), the latter two variants were predicted
to have less functional impact on SLC20A1 protein function.
As outlined earlier, the BEEC incorporates a spectrum
of severity, which includes the mildest form, epispadias; the
intermediate form, CBE; and the most severe form, CE, also
called the omphalocele, exstrophy, imperforate anus, and spinal
defects (OEIS) complex (BEEC; OMIM%600057) (phenotypical
pictures and more detailed description in Supplementary Data
Sheet S12 (taken from Ebert et al., 2009). The BEEC is the
most severe of all human CAKUT. Most affected individuals
have impaired fertility despite operative reconstruction, and
therefore the anomaly remains nearly always sporadic. Hence,
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the pathogenesis of BEEC might be explained by as yet undefined
genetic de novo perturbations or environmental.
The SR101 assay showed high abundance of opening defects
of the hindgut among slc20a1a MO KD zfl, resembling
the imperforate anus and rectal agenesis in human CE
individuals (Diamond and Jeffs, 1985). The enhanced embryonic
lethality of slc20a1a morphants reflects the high mortality
of CE, which was always fatal prior to the 1960s, when
most affected individuals would die in the neonatal period
(Lund and Hendren, 1993; Inouye et al., 2014). Therefore,
our findings of cystic dilatations of the pronephros, cloacal
disorganization, and hindgut opening defects in slc20a1a
morphants together with the observed expression of SLC20A1
in the urogenital sinus in a 6-week-old human embryo and
the expression of SLC20A1 in a 10-week-gestation metanephric
kidney suggest SLC20A1 to be involved in urinary tract and
urorectal development.
In slc20a1a morphants, we saw several additional phenotypic
features including growth retardation, defects of the tail
and body formation, hydrocephalus, and defects in yolk sac
endocytosis (Figure 1A). Accordingly, human CE presents with
the exstrophic bladder, omphalocele, a rudimentary hindgut
proximal to an imperforate anus, spinal defects, and intracranial
anomalies comprising hydrocephalus, Chiari malformations,
and craniosynostosis (Diamond and Jeffs, 1985), resembling
all affected organ systems seen in slc20a1a morphants. While
this phenotypic overlap of human CE phenotypes and slc20a1a
morphants might be phenotypic overlap by chance, the multitude
of affected overlapping organ system is suggestive of a specific
effect in slc20a1a morphants. While our G III–IV MO KD
phenotype (Figure 1A) resembles almost all if not all affected
organ systems of the human CE phenotype, the milder
affected slc20a1a MO zfl (G II) might resemble the broad
phenotypic spectrum of BEEC ranging from diastasis of the
symphysis only to epispadias, CBE, CE, and rare variants
(Maruf et al., 2019).
Our present study supports zfl experiments for functional
characterization of apparent disease genes and variants in human
CAKUT phenotypes and/or congenital anorectal malformations.
Additionally, our results suggest SLC20A1 to be involved in
urinary tract and urorectal development and implicate SLC20A1
as a disease-gene for human BEEC.
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